In a first, brain implant lets man with complete paralysis spell out thoughts: ‘I love my cool son.’
By Kelly Servick,
Science
| 03. 22. 2022
In its final stages, the neurological disease amyotrophic lateral sclerosis (ALS) can bring extreme isolation. People lose control of their muscles, and communication may become impossible. But with the help of an implanted device that reads his brain signals, a man in this “complete” locked-in state could select letters and form sentences, researchers report this week.
“People have really doubted whether this was even feasible,” says Mariska Vansteensel, a brain-computer interface researcher at the University Medical Center Utrecht who was not involved in the study, published in Nature Communications. If the new spelling system proves reliable for all people who are completely locked in—and if it can be made more efficient and affordable—it might allow thousands of people to reconnect to their families and care teams, says Reinhold Scherer, a neural engineer at the University of Essex.
ALS destroys the nerves that control movement, and most patients die within 5 years of diagnosis. When a person with ALS can no longer speak, they can use an eye-tracking camera to select letters on a screen. Later in the disease’s...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...